Burden of hypertensive heart disease and its attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Jinhang Che und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiographic Diagnosis, The Fourth People's Hospital of Chengdu, Chengdu, China. Hauptthemen laut MEDLINE: Hypertension, Heart Diseases. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Hypertensive heart disease (HHD) remains a significant global health issue.
Methods
This study analysed the global, regional, and national burden of HHD from 1990 to 2021.
Results
In 2021, the global prevalence, deaths, and disability‐adjusted life years (DALYs) associated with HHD were 12.5 million, 1.3 million and 25.5 million, respectively, exhibiting age‐standardized percentage changes of 18.2%, −22.0% and −25.8% compared to 1990. Jordan (341.9), Bulgaria (103.4) and Bulgaria (1739.3) had the highest age‐standardized prevalence, death and DALY rates, respectively, while Belarus recorded the lowest rates. DALYs reached their zenith in the 70–74 age range, but age‐standardized DALY rates were rising in the oldest age group (≥95). A negative correlation was observed between the sociodemographic index and DALY rates. The key risk factors identified were high systolic blood pressure (100%), high BMI (49.3%) and insufficient fruit intake (37.8%).
Conclusion
Although case numbers have increased, age‐standardised death and DALY rates have declined since 1990. Targeted prevention strategies should prioritise blood pressure control, weight management and dietary measures to mitigate the burden of HHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrocardiographic Diagnosis, The Fourth People's Hospital of Chengdu, Chengdu, China.
- Department of Tuberculosis, Public Health Clinical Center of Chengdu, Chengdu, China.
- Department of Ultrasonography, The Fourth People's Hospital of Chengdu, Chengdu, China.
- Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Jinhang Che, Zengzhang Liu
Zitieren
APA
Che, J., Wang, Y., Luo, L., Tang, Y., Huai, J., Zeng, T., & Liu, Z. (2026). Burden of hypertensive heart disease and its attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70104
Vancouver
Che J, Wang Y, Luo L, Tang Y, Huai J, Zeng T, et al. Burden of hypertensive heart disease and its attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70104
BibTeX
@article{Che2026,
author = {Che, Jinhang and Wang, Yi and Luo, Lihong and Tang, Yunxiang and Huai, Jie and Zeng, Tao and Liu, Zengzhang},
title = {Burden of hypertensive heart disease and its attributable risk factors in 204 countries and territories, 1990–2021: Results from the global burden of disease study 2021},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70104}
}
EUVIMED